Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

137.86p
   
  • Change Today:
      6.86p
  • 52 Week High: 168.00p
  • 52 Week Low: 108.00p
  • Currency: UK Pounds
  • Shares Issued: 84.90m
  • Volume: 116,900
  • Market Cap: £117.04m
  • RiskGrade: 196
  • Beta: 0.44

Latest ShareCast News

PDMR Shareholding/SIP & Total Voting Rights

By Sharecast

Date: Tuesday 23 Dec 2025

Diaceutics strengthens partnership with Partner Therapeutics

By Josh White

Date: Wednesday 26 Mar 2025

(Sharecast News) - Diaceutics announced on Wednesday that it has strengthened its commercial partnership with Partner Therapeutics, the new US licence holder of the oncology precision medicine 'Bizengri', or zenocutuzumab, with an enhanced multi-year agreement for its PMx commercialisation services.

Diaceutics wins $5.1m contract with global pharma firm

By Josh White

Date: Tuesday 17 Dec 2024

(Sharecast News) - Diaceutics announced on Tuesday that it has won a $5.1m contract with a global pharmaceutical company to deliver laboratory engagement services through its DXRX platform.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 137.86p
Change Today 6.86p
% Change 5.23 %
52 Week High 168.00p
52 Week Low 108.00p
Volume 116,900
Shares Issued 84.90m
Market Cap £117.04m
Beta 0.44
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.57% below the market average33.57% below the market average33.57% below the market average33.57% below the market average33.57% below the market average
51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average
Price Trend
29.40% above the market average29.40% above the market average29.40% above the market average29.40% above the market average29.40% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Income Not Available
Growth
48.02% above the market average48.02% above the market average48.02% above the market average48.02% above the market average48.02% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

Diaceutics Dividends

No dividends found

Trades for 06-Jan-2026

Time Volume / Share Price
12:36 10,000 @ 137.25p
12:35 7,500 @ 137.50p
12:35 7,500 @ 137.50p
10:24 25,000 @ 137.00p
11:19 1,500 @ 138.00p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page